This early study tests an oral drug called BTX-A51 in 24 people with advanced liposarcoma (a type of fat tissue cancer) that has spread or come back. The main goal is to see if the drug is safe and tolerable at different doses. It focuses on specific genetic subtypes: MDM2-amplif…
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC